Shareholders' equity · 2011–2025
Corcept Therapeutics shareholders' equity
$648M−4.7% · FY2025
Corcept Therapeutics (CORT) reported $648M in shareholders' equity for fiscal 2025, −4.7% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $648M | −4.7% | Open → |
| FY20242024-12-31 | $680M | +34.1% | Open → |
| FY20232023-12-31 | $507M | +1.0% | Open → |
| FY20222022-12-31 | $502M | +33.5% | Open → |
| FY20212021-12-31 | $376M | −28.2% | Open → |
| FY20202020-12-31 | $523M | +41.0% | Open → |
| FY20192019-12-31 | $371M | +34.5% | Open → |
| FY20182018-12-31 | $276M | +44.5% | Open → |
| FY20172017-12-31 | $191M | +361.5% | Open → |
| FY20162016-12-31 | $41.4M | +123.7% | Open → |
| FY20152015-12-31 | $18.5M | +$21.9M | Open → |
| FY20142014-12-31 | −$3.4M | −$24.4M | Open → |
| FY20132013-12-31 | $21.0M | −66.0% | Open → |
| FY20122012-12-31 | $61.8M | +77.5% | Open → |
| FY20112011-12-31 | $34.8M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +23.2%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Corcept Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/corcept-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Corcept Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/corcept-therapeutics/shareholders-equityBibTeX
@misc{companiesranked-en-company-corcept-therapeutics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Corcept Therapeutics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/corcept-therapeutics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001628280-26-050613 · July 29, 2026
{{cite web |title=Corcept Therapeutics shareholders' equity — 10-Q (0001628280-26-050613) |url=https://www.sec.gov/Archives/edgar/data/1088856/000162828026050613/cort-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.